Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
- PMID: 15172979
- DOI: 10.1158/0008-5472.CAN-04-0637
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
Abstract
In this study, we report for the first time reduced expression of the let-7 microRNA in human lung cancers. Interestingly, 143 lung cancer cases that had undergone potentially curative resection could be classified into two major groups according to let-7 expression in unsupervised hierarchical analysis, showing significantly shorter survival after potentially curative resection in cases with reduced let-7 expression (P = 0.0003). Multivariate COX regression analysis showed this prognostic impact to be independent of disease stage (hazard ratio = 2.17; P = 0.009). In addition, overexpression of let-7 in A549 lung adenocarcinoma cell line inhibited lung cancer cell growth in vitro. This study represents the first report of reduced expression of let-7 and the potential clinical and biological effects of such a microRNA alteration.
Similar articles
-
Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.Cancer Res. 2010 Jan 1;70(1):36-45. doi: 10.1158/0008-5472.CAN-09-3153. Epub 2009 Dec 22. Cancer Res. 2010. PMID: 20028859
-
Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.Oncol Rep. 2004 Oct;12(4):849-53. Oncol Rep. 2004. PMID: 15375511
-
Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.Lung Cancer. 2009 Mar;63(3):410-7. doi: 10.1016/j.lungcan.2008.06.003. Epub 2008 Jul 11. Lung Cancer. 2009. PMID: 18620780
-
Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.Cancer. 2007 Jul 1;110(1):215-23. doi: 10.1002/cncr.22743. Cancer. 2007. PMID: 17508409
-
Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.Cancer Res. 2010 Dec 15;70(24):10392-401. doi: 10.1158/0008-5472.CAN-10-2341. Cancer Res. 2010. PMID: 21159652
Cited by
-
Identification of potential plasma biomarkers in early-stage nasopharyngeal carcinoma-derived exosomes based on RNA sequencing.Cancer Cell Int. 2021 Mar 31;21(1):185. doi: 10.1186/s12935-021-01881-4. Cancer Cell Int. 2021. PMID: 33789676 Free PMC article.
-
An Integrative Omics Approach Reveals Involvement of BRCA1 in Hepatic Metastatic Progression of Colorectal Cancer.Cancers (Basel). 2020 Aug 22;12(9):2380. doi: 10.3390/cancers12092380. Cancers (Basel). 2020. PMID: 32842712 Free PMC article.
-
MicroRNA let-7b inhibits cell proliferation via upregulation of p21 in hepatocellular carcinoma.Cell Biosci. 2020 Jul 1;10:83. doi: 10.1186/s13578-020-00443-x. eCollection 2020. Cell Biosci. 2020. PMID: 32626571 Free PMC article.
-
Circulating Plasma microRNA to Differentiate Cushing's Disease From Ectopic ACTH Syndrome.Front Endocrinol (Lausanne). 2020 Jun 5;11:331. doi: 10.3389/fendo.2020.00331. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32582027 Free PMC article.
-
Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer.J Clin Lab Anal. 2021 May;35(5):e23743. doi: 10.1002/jcla.23743. Epub 2021 Mar 8. J Clin Lab Anal. 2021. PMID: 33682961 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical